Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Lucà

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Diabetologica|June 7, 2024
The relationship between endothelial-dependent flow-mediated dilation and diastolic function in type 2 diabetesAntonio Cutruzzolà, Martina Parise, Michele Cacia, et al.
Journal of Translational Medicine|February 21, 2023
Very low-calorie ketogenic diet (VLCKD): an antihypertensive nutritional approachLuigi Barrea, Ludovica Verde, Pasquale Santangeli, et al.
Life (Basel, Switzerland)|October 27, 2022
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic OptionsMaria Chiara Pelle, Isabella Zaffina, Stefania Lucà, et al.
Nutrients|February 26, 2025
Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal ImpairmentLudovica Verde, Luigi Barrea, Martina Galasso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 28, 2024
The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetesAntonio Cutruzzolà, Martina Parise, Faustina Barbara Scavelli, et al.
Life (Basel, Switzerland)|January 21, 2022
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to TreatmentMaria Chiara Pelle, Michele Provenzano, Isabella Zaffina, et al.
Current Obesity Reports|March 18, 2023
The Fat KidneyLudovica Verde, Stefania Lucà, Simona Cernea, et al.
Frontiers in Endocrinology|August 29, 2022
Effects of sacubitril/valsartan on both metabolic parameters and insulin resistance in prediabetic non-obese patients with heart failure and reduced ejection fractionCosima Cloro, Isabella Zaffina, Luca Sacchetta, et al.
Minerva Endocrinology|July 1, 2026
Cardiometabolic and renal complications of obesity: an updated comprehensive overview by SIO - Campania regionRenata Bracale, Ludovica Verde, Sonja Chiappetta, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Diabetologica|June 7, 2024
The relationship between endothelial-dependent flow-mediated dilation and diastolic function in type 2 diabetesAntonio Cutruzzolà, Martina Parise, Michele Cacia, et al.
Journal of Translational Medicine|February 21, 2023
Very low-calorie ketogenic diet (VLCKD): an antihypertensive nutritional approachLuigi Barrea, Ludovica Verde, Pasquale Santangeli, et al.
Life (Basel, Switzerland)|October 27, 2022
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic OptionsMaria Chiara Pelle, Isabella Zaffina, Stefania Lucà, et al.
Nutrients|February 26, 2025
Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal ImpairmentLudovica Verde, Luigi Barrea, Martina Galasso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 28, 2024
The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetesAntonio Cutruzzolà, Martina Parise, Faustina Barbara Scavelli, et al.
Life (Basel, Switzerland)|January 21, 2022
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to TreatmentMaria Chiara Pelle, Michele Provenzano, Isabella Zaffina, et al.
Current Obesity Reports|March 18, 2023
The Fat KidneyLudovica Verde, Stefania Lucà, Simona Cernea, et al.
Frontiers in Endocrinology|August 29, 2022
Effects of sacubitril/valsartan on both metabolic parameters and insulin resistance in prediabetic non-obese patients with heart failure and reduced ejection fractionCosima Cloro, Isabella Zaffina, Luca Sacchetta, et al.
Minerva Endocrinology|July 1, 2026
Cardiometabolic and renal complications of obesity: an updated comprehensive overview by SIO - Campania regionRenata Bracale, Ludovica Verde, Sonja Chiappetta, et al.
Pageof 1